Cited by 38Colorectal Cancer Screening and DetectionCancer survivorship and careColorectal Cancer Surgical Treatments

Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system

Open access
Laing, Sharon S., Bogart, Andy, Chubak, Jessica, Fuller, Sharon, Green, Beverly B.·2014·Cancer Epidemiology, Biomarkers & Prevention

Abstract

Background: Colorectal cancer screening (CRCS) reduces morbidity and mortality; however, the positive benefits might be partially offset by long-term distress following positive screening results. We examined relationships among colorectal cancer–specific worry and situational anxiety after positive fecal occult blood tests [FOBT (+)] compared with receipt of negative results. Methods: Of note, 2,260 eligible members of Group Health, an integrated healthcare delivery system, completed baseline surveys and received FOBT screening kits, with 1,467 members returning the kits. We matched FOBT (+) patients (n = 55) 1:2 on age and sex with FOBT (−) respondents (n = 110). Both groups completed follow-up surveys at 7 to 14 days and 4 months after screening. We assessed situational anxiety (State-Trait Anxiety Inventory, STAI), colorectal cancer worry frequency, and mood disturbance. Results: Mean age was 59 years, and majority were women (62%) and White (89%). After adjusting for age, sex, and baseline worry, at 7 to 14 days after screening, the FOBT (+) group was 3.82 [95% confidence interval (CI), 1.09–13.43] times more likely to report colorectal cancer–related mood disturbances and significantly higher mean STAI scores than the FOBT (−) group (mean = 38.8 vs. 30.9; P = 0.007). At 4-month posttest, mood disturbances and situational anxiety seemed to drop to baseline levels for FOBT (+). No colon cancer worry frequency was observed. Conclusions: FOBT (+) results are associated with short-term situational anxiety and colorectal cancer–specific mood disturbances. Impact: Distress from FOBT (+) results declined to near-baseline levels by 4 months. Additional studies are needed to clarify the relationship between long-term distress and follow-up colonoscopy. Cancer Epidemiol Biomarkers Prev; 23(1); 154–9. ©2013 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-13-0722

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • STAI has been used in breast, colon, and lung cancer screening programs and in patients with cirrhosis.

    “which has been used in breast, colon, and lung cancer screening programs24–26 and in patients with cirrhosis.27”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Laing, S. S., Bogart, A., Chubak, J., Fuller, S., & Green, B. B.
Affiliations
  • University of Washington (US)
  • Kaiser Permanente Washington Health Research Institute (US)
Corresponding author
Laing, Sharon S.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2014-01-01
Volume
23
Issue
1
Pages
154-159
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2128132717
Cited by
38
References
27
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 1
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • University of Washington Tacoma Digital Commons (University of Washington Tacoma) (submittedVersion)
Funders
National Cancer Institute (R01CA121125)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords
fecal occult blood test, positive screening results, psychological distress, state anxiety, mood disturbance, colorectal cancer screening, integrated health system, Group Health, follow-up colonoscopy
MeSH terms
Anxiety, Delivery of Health Care, Female, Humans, Male, Middle Aged, Occult Blood, Surveys and Questionnaires, Reagent Kits, Diagnostic, Colorectal Neoplasms, Delivery of Health Care, Integrated, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review